Healthcare - Biotechnology - NASDAQ - US
$ 26.5
-9.99 %
$ 172 M
Market Cap
-1.44
P/E
CASH FLOW STATEMENT
-82 M
OPERATING CASH FLOW
41.1 M
INVESTING CASH FLOW
8.08 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Instil Bio, Inc.
| Net Income | -156 M |
| Depreciation & Amortization | 4.76 M |
| Capital Expenditures | -20.7 M |
| Stock-Based Compensation | 18.2 M |
| Change in Working Capital | -9.02 M |
| Others | 51.1 M |
| Free Cash Flow | -103 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (156.1) | (223.2) | (156.8) | (37.7) | (6.5) |
| Depreciation & Amortization | 4.8 | 6.0 | 2.8 | 0.3 | 20 K |
| Deferred Income Tax | 1.1 | 0 | 0.7 | (0.6) | 0 |
| Stock Based Compensation | 18.2 | 30.4 | 26.2 | 1.7 | 0.3 |
| Other Operating Activities | 59.0 | 16.2 | 0.6 | 5.3 | 0.6 |
| Change in Working Capital | (9.0) | (9.6) | 4.4 | 1.5 | 0.4 |
| Cash From Operations | (82.0) | (180.2) | (122.1) | (29.6) | (5.3) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (20.7) | (84.6) | (57.8) | (50.8) | (0.8) |
| Other Items | 61.8 | 199.1 | (416.6) | (0.3) | 0 |
| Cash From Investing Activities | 41.1 | 114.5 | (474.4) | (51.1) | (0.8) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 8.1 | 70.3 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 1.5 | 54.1 | 313.0 | 14.9 |
| Cash From Financing Activities | 8.1 | 71.9 | 393.2 | 313.0 | 14.9 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (33.0) | 5.6 | (203.7) | 232.9 | 8.9 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (102.7) | (264.8) | (180.0) | (80.4) | (6.1) |